WASHINGTON, Aug. 4 -- The U.S. Department of Health and Human Services National Institutes of Health announced that it expects to award a grant for early-stage therapy development for Alzheimer's disease and related dementias. The agency description of the grant states: "This funding opportunity announcement (FOA) encourages early-stage development of novel small molecule or biologic therapeutics for NINDS mission-relevant? Alzheimer's and related dementias: frontotemporal degeneration (FTD, in more ST